3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
58
Gastrointestinal
24
Breast
4
Thoracic
3
Other solid neoplasm
2
Genitourinary
2
Endocrine
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Head & Neck
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
143
Gastro-enteropancreatic neuroendocrine tumor
29
Carcinoma, Neuroendocrine
18
Neoplasms
15
Breast Neoplasms
13
Adenoma, Islet Cell
13
Prostatic Neoplasms
11
Carcinoma, Hepatocellular
11
Carcinoid Tumor
11
Stomach Neoplasms
10
Pheochromocytoma
10
Pancreatic Neoplasms
10
Colorectal Neoplasms
10
Sarcoma
9
Paraganglioma
9
Thyroid Neoplasms
8
Neoplasm Metastasis
8
Lung Neoplasms
8
Cholangiocarcinoma
8
Small Cell Lung Carcinoma
7
Ovarian Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Anus Neoplasms
7
Rectal Neoplasms
6
Mesothelioma
6
Colonic Neoplasms
6
Carcinoma
6
Brain Neoplasms
6
Uterine Cervical Neoplasms
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
NET
×
1 year
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled